CHP/PCOR Events

Cost-Effectiveness Analysis of HIV Vaccines

Research in Progress Seminar

Date and Time
July 18, 2001
1:30 PM - 3:00 PM

Availability
Open to the public
No RSVP required

Speaker
DK Owens

Topics: Health policy

Location
CHP/PCOR Conference Room
117 Encina Commons, Room 119
Stanford University
Stanford, CA 94305
» Directions/Map

FSI Contact
Kathryn M. McDonald

Non-FSI Contact
Elaine Steel, 650-723-6426

Parent Research Projects

Evaluating the Cost and Benefits of Potential Preventive and Therapeutic HIV Vaccines
DK Owens
Clopidogrel Versus Aspirin for Secondary Prophylaxis of Thrombotic Events: A Cost-Effectiveness Analysis
Mark Schleinitz
Cost-Effectiveness Analyses: Cost-Effectiveness of Vaccinating College Freshmen against Meningitis
Gillian D. Sanders, P Bilir, C Rydzak
HIV in Russia: The Cost-Effectiveness of Treating Injection Drug Users with Antiretroviral Therapy
Elisa Long

Screening Surgeons for HIV Infection: A Cost-Effectiveness Analysis
Douglas K. Owens, R.A. Harris , P.M.J. Scott, R.F. Nease
Annals of Internal Medicine vol. 122 (1995)
Expanded Screening for HIV in the United States: An Analysis of Cost-Effectiveness
A. David Paltiel, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, Freedberg KA, Walensky RP
New England Journal of Medicine vol. 352 (2005)
Limitations of Cost-Benefit Analysis and Cost-Effectiveness Analysis in Health Care
Byung Kwang Yoo
Noushinkeigeka sokuhou (trans. Currently Practical Neurosurgery) vol. 13, 5 (2003)
Applications of Cost-Benefit Analysis and Cost-Effectiveness Analysis in Health Policy-making
Byung Kwang Yoo
Noushinkeigeka sokuhou (trans. Currently Practical Neurosurgery) vol. 13, 6 (2003)